Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
NCT00266864Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2003
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Testosterone TEPI patch in Hypogonadism (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Dual Energy X-ray Absorptiometry (DXA) Assessment of Lean Tissue Mass at 12 months. Started Aug 2003; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00266864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266864.